For the Inventor, By the Inventor

Enter assignee name

Maidenhead, United Kingdom

John Wyeth Brother, Limited

USPTO Granted Patents = 299

CIPO Patents = 1

Forward Citations = 2,128

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Roger Crossley (63 out of 66 patents)

Terence J Ward (49 out of 52 patents)

Alan C White (46 out of 46 patents)

4. John Leheup Archibald (43 out of 43 patents)

5. Ian A Cliffe (34 out of 37 patents)

6. Adrian Charles Curran (31 out of 32 patents)

7. Robin G Shepherd (25 out of 25 patents)

8. John T Boyle (16 out of 17 patents)

9. Albert Opalko (14 out of 15 patents)

10. John Frederick Cavalla (14 out of 14 patents)

11. David George Hill (13 out of 13 patents)

12. John F White (12 out of 12 patents)

13. John Lambert Jackson (11 out of 11 patents)

14. Robin Michael Black (9 out of 9 patents)

15. Richard S Todd (9 out of 12 patents)

Core Competencies:

Piperazine Derivatives

5-HT Antagonists

Nitrogen Heterocycles

Pharmaceutical Package

Cognitive Disorders Treatment

Bicyclic Carboxamides

Optically Active Amides

Azabicyclic Derivatives

Pharmacologically Active Amides

Potassium Channel Modulators

Azetidine Derivatives

Cyclohexane Derivatives

299 patents: Sort by Forward Citations

1. 6395902 - Oxathiazolidinyl pyridines (2002-05-28),

2. 6175012 - Processes and intermediates for the preparation of piperazine derivatives (2001-01-16),

3. 6133449 - Processes and intermediates for the preparation of piperazine derivatives (2000-10-17),

4. 6127357 - N-((phenyl, benzodioxinyl or (2000-10-03),

5. 6056942 - 5-HT.sub.1A ligands (2000-05-02),

6. 5965696 - Potassium channel modulators (1999-10-12),

7. D404641 - Pharmaceutical package (1999-01-26),

8. 5827847 - Treatment of cognitive disorders with piperazine derivatives (1998-10-27),

9. 5821251 - Nitrogen heterocycles (1998-10-13),

10. 5763460 - N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides (1998-06-09),

11. 5710149 - Piperazine derivatives as 5-ht antagonists (1998-01-20),

12. 5708026 - Cyclohexane derivatives (1998-01-13),

13. 5693642 - Piperazine derivatives as 5-HT.sub.1A ligands (1997-12-02),

14. 5681839 - Nitrogen heterocycles (1997-10-28),

15. 5637701 - Process for preparing optically active amide derivatives (1997-06-10),

John Wyeth Brother, Limited is a historical pharmaceutical company known for its contributions to the development of various medicinal products. Established in the 19th century, the company has a rich legacy in the healthcare sector, focusing on innovation and quality in its offerings. Over the years, it has played a significant role in the evolution of pharmaceuticals, adapting to the changing needs of the medical community and patients alike. The company is recognized for its commitment to research and development, ensuring that it remains at the forefront of the industry. Although it may not be as prominent today, its historical impact on medicine and healthcare continues to be acknowledged.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

299 Patents

#1 in Maidenhead

#52 in United Kingdom

#2,900 in the World

Maidenhead, United Kingdom

John Wyeth Brother, Limited

Forward Citations = 2,128

84 inventors:

Roger Crossley (63 out of 66 patents)

Terence J Ward (49 out of 52 patents)

Alan C White (46 out of 46 patents)

4. John Leheup Archibald (43 out of 43 patents)

5. Ian A Cliffe (34 out of 37 patents)

Please report any incorrect information to support@idiyas.com

Loading…